Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Teladoc ( (TDOC) ) just unveiled an announcement.
On July 17, 2025, Teladoc Health, Inc. entered into a credit agreement with JPMorgan Chase Bank, establishing a $300 million senior secured revolving credit facility to enhance financial and operational flexibility. The facility, which has a five-year term, is designed to support Teladoc’s strategic initiatives without immediate borrowing plans, and includes financial covenants to maintain leverage and interest coverage ratios.
The most recent analyst rating on (TDOC) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Teladoc stock, see the TDOC Stock Forecast page.
Spark’s Take on TDOC Stock
According to Spark, TipRanks’ AI Analyst, TDOC is a Neutral.
Teladoc’s stock score is primarily influenced by its financial performance challenges and valuation concerns. Positive aspects include technical momentum and strategic initiatives discussed in the earnings call, but these are offset by profitability issues and lack of dividend income.
To see Spark’s full report on TDOC stock, click here.
More about Teladoc
Teladoc Health, Inc. operates in the telemedicine industry, providing virtual healthcare services. The company focuses on delivering remote medical consultations and healthcare solutions to enhance patient access and convenience.
Average Trading Volume: 6,476,022
Technical Sentiment Signal: Sell
Current Market Cap: $1.48B
For a thorough assessment of TDOC stock, go to TipRanks’ Stock Analysis page.